LEADER 02585nam  2200601 a 450 
001 9910781003703321
005 20230725051730.0
010   $a0-309-18648-X
010   $a1-282-97591-9
010   $a9786612975912
010   $a0-309-14884-7
035   $a(CKB)2550000000032080
035   $a(SSID)ssj0000467759
035   $a(PQKBManifestationID)11320034
035   $a(PQKBTitleCode)TC0000467759
035   $a(PQKBWorkID)10490553
035   $a(PQKB)10059879
035   $a(MiAaPQ)EBC3378727
035   $a(Au-PeEL)EBL3378727
035   $a(CaPaEBR)ebr10443269
035   $a(CaONFJC)MIL297591
035   $a(OCoLC)709768285
035   $a(EXLCZ)992550000000032080
100   $a20110215d2010      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aCNS clinical trials$b[electronic resource] $esuicidality and data collection : workshop summary /$fSarah Hanson, Miriam Davis, and Bruce Altevogt ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy
210   $aWashington, D.C. $cNational Academies Press$d2010
215   $axii, 75 p
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-14883-9 
327   $aPerspectives from the FDA, academia, and patients -- Data collection and optimization -- Data analysis -- Partnerships, opportunities, collaboration.
330   $a"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future."--Publisher's description.
606   $aSuicide$xRisk factors
606   $aSuicide$xPrevention
615  0$aSuicide$xRisk factors.
615  0$aSuicide$xPrevention.
676   $a616.85/8445
700   $aHanson$b Sarah$01530878
701   $aDavis$b Miriam$0856948
701   $aAltevogt$b Bruce M$01478507
712 02$aInstitute of Medicine (U.S.).$bForum on Neuroscience and Nervous System Disorders.
712 02$aNational Academies Press (U.S.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910781003703321
996   $aCNS clinical trials$93842899
997   $aUNINA